Loading organizations...
Loading organizations...
Developing small molecule therapeutics for neurodegeneration treatment.
Magnolia NeuroSciences has raised $31.0M across 1 funding round.
Magnolia NeuroSciences has raised $31.0M in total across 1 funding round.
Magnolia NeuroSciences has raised $31.0M in total across 1 funding round.
Magnolia NeuroSciences's investors include 180 Degree Capital, AbbVie Ventures, Alexandria Venture Investments, ARCH Venture Partners, Eli Lilly and Company, Innovate NY Fund, Johnson & Johnson Innovation, Partnership Fund for New York City, Watson Fund, WuXi AppTec.
Magnolia NeuroSciences has raised $31.0M across 1 funding round. Most recently, it raised $31.0M Series A in August 2018.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 13, 2018 | $31.0M Series A | 180 Degree Capital, AbbVie Ventures, Alexandria Venture Investments, ARCH Venture Partners, Eli Lilly and Company, Innovate NY Fund, Johnson & Johnson Innovation, Partnership Fund for New York City, Watson Fund, WuXi AppTec |